These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21618333)

  • 21. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review.
    Kalus S; Saifuddin A
    Eur Radiol; 2019 Oct; 29(10):5700-5708. PubMed ID: 30915559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastases.
    Stecco A; Lombardi M; Leva L; Brambilla M; Negru E; Delli Passeri S; Carriero A
    Radiol Med; 2013 Apr; 118(3):465-75. PubMed ID: 22872462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-body magnetic resonance imaging for detecting bone metastases: comparison with bone scintigraphy.
    Cascini G; Falcone C; Greco C; Bertucci B; Cipullo S; Tamburrini O
    Radiol Med; 2008 Dec; 113(8):1157-70. PubMed ID: 18958408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa).
    Lecouvet FE; Simon M; Tombal B; Jamart J; Vande Berg BC; Simoni P
    Eur Radiol; 2010 Dec; 20(12):2973-82. PubMed ID: 20661742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study.
    Michielsen KL; Vergote I; Dresen R; Op de Beeck K; Vanslembrouck R; Amant F; Leunen K; Moerman P; Fieuws S; De Keyzer F; Vandecaveye V
    Br J Radiol; 2016 Nov; 89(1067):20160468. PubMed ID: 27585490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer.
    Lecouvet FE; Pasoglou V; Van Nieuwenhove S; Van Haver T; de Broqueville Q; Denolin V; Triqueneaux P; Tombal B; Michoux N
    Eur Radiol; 2020 Jun; 30(6):3083-3093. PubMed ID: 32065282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D; Patti C; Lagalla R; Midiri M; Galia M
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
    Pfannenberg C; Schwenzer N
    Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods.
    Goo HW; Choi SH; Ghim T; Moon HN; Seo JJ
    Pediatr Radiol; 2005 Aug; 35(8):766-73. PubMed ID: 15864576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.
    Mosavi F; Laurell A; Ahlström H
    Acta Oncol; 2015 Nov; 54(10):1763-9. PubMed ID: 25975210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams.
    Nakanishi K; Kobayashi M; Takahashi S; Nakata S; Kyakuno M; Nakaguchi K; Nakamura H
    Magn Reson Med Sci; 2005; 4(1):11-7. PubMed ID: 16127249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
    Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
    PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body MRI-based multivariate prediction model in the assessment of bone metastasis in prostate cancer.
    Chen R; Yang Q; Chen W; Yang Y; Cheng C; Sun Y; Lu J
    World J Urol; 2021 Aug; 39(8):2937-2943. PubMed ID: 33521882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours.
    Kembhavi SA; Rangarajan V; Shah S; Qureshi S; Arora B; Juvekar S; Laskar S; Vora T; Chinnaswamy G; Ramadwar M; Kurkure P
    Clin Radiol; 2014 Sep; 69(9):900-8. PubMed ID: 24863003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-body MRI: detecting bone metastases from prostate cancer.
    Nakanishi K; Tanaka J; Nakaya Y; Maeda N; Sakamoto A; Nakayama A; Satomura H; Sakai M; Konishi K; Yamamoto Y; Nagahara A; Nishimura K; Takenaka S; Tomiyama N
    Jpn J Radiol; 2022 Mar; 40(3):229-244. PubMed ID: 34693502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
    Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
    Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
    Mosavi F; Johansson S; Sandberg DT; Turesson I; Sörensen J; Ahlström H
    AJR Am J Roentgenol; 2012 Nov; 199(5):1114-20. PubMed ID: 23096187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pooled analysis of diffusion-weighted imaging in the diagnosis of hepatocellular carcinoma in chronic liver diseases.
    Wu LM; Xu JR; Lu Q; Hua J; Chen J; Hu J
    J Gastroenterol Hepatol; 2013 Feb; 28(2):227-34. PubMed ID: 23190006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.